[CUE] YoY Quarter Result on 30-Jun-2024 [#Q2]

Stock
[CUE] Cue Biopharma, Inc.
Announcement Date
14-Aug-2024
Financial Year
2024
Quarter
30-Jun-2024 [#Q2]
Profit Trend
QoQ- 17.62%
YoY- 22.86%
Quarter Report
CUE's Result
CUE's Financial Summary
View:
Show?
Quarter Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Revenue 2,658 1,382 26 2,739 1,075 1,055 172 57.75%
PBT -10,171 -13,185 -13,208 -10,279 -10,833 -9,109 -7,300 5.67%
Tax 0 564 118 0 618 413 -170 -
NP -10,171 -13,185 -13,326 -10,279 -10,833 -9,522 -7,300 5.67%
Tax Rate - - - - - - - -
Total Cost 12,829 14,567 13,352 13,018 11,908 10,577 7,472 9.41%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
NP Margin -382.66 -954.05 -51,253.85 -375.28 -1,007.72 -902.56 -4,244.19 -33.01%
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
EPS -0.20 -0.29 -0.38 -0.33 -0.38 -0.46 -0.36 -9.32%
EPS Diluted -0.20 -0.29 -0.38 -0.33 -0.38 -0.46 -0.36 -9.32%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.